Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Operating Expenses | 11,715 | 27,635 | 10,156 | 2,690 | 0 |
| Operating Income | -11,715 | -27,635 | -10,156 | -2,690 | N/A |
| Interest Expense | 0 | 775 | 706 | 0 | 0 |
| Other Income | 0 | 1,456 | 0 | 0 | 0 |
| Pre-tax Income | -11,715 | -26,953 | -10,862 | -2,690 | 0 |
| Net Income Continuous | -11,715 | -26,953 | -10,862 | -2,690 | N/A |
| Minority Interests | -105 | N/A | N/A | N/A | N/A |
| Net Income | $-11,610 | $-26,953 | $-10,862 | $-2,690 | $N/A |
| EPS Basic Total Ops | -0.55 | -1.56 | -0.81 | -0.22 | N/A |
| EPS Basic Continuous Ops | -0.56 | -1.56 | -0.81 | -0.22 | N/A |
| EPS Diluted Total Ops | -0.55 | -1.56 | -0.81 | -0.22 | N/A |
| EPS Diluted Continuous Ops | -0.56 | -1.56 | -0.81 | -0.22 | N/A |
| EBITDA(a) | $-11,713 | $-27,633 | $-10,154 | $-2,689 | $N/A |